Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 67

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 67
---
 connection with the June 2024 private placement, we entered into a registration rights agreement with the investors pursuant to which we agreed to file with the SEC a registration statement registering the resale of the shares sold in the June 2024 private placement. This resale registration statement was filed with the SEC on July 10, 2024 and declared effective by the SEC on July 18, 2024. Under the terms of the registration rights agreement, we agreed to keep this resale registration statement effective at all times until the shares are no longer considered “Registrable Securities” under the registration rights agreement and if we fail to keep the resale registration statement effective, subject to certain permitted exceptions, we will be required to pay liquidated damages to the investors in an amount of up to 10% of the invested capital, excluding interest. We also agreed, among other things, to indemnify the selling holders under the resale registration statement from certain liabilities and to pay all fees and expenses incident to our performance of or compliance with the registration rights agreement.

On June 21, 2023, we issued and sold an aggregate 11,011,406 common shares pursuant to a securities purchase agreement at a purchase price of $3.40 per share, or $3.91 per share in the case of our participating directors and officers, in a private placement. As a result of the offering, we received gross proceeds of $37.5 million, which resulted in net proceeds to us of approximately $36.1 million, after deducting the offering expenses.

<div align='center'>56</div>

The following directors, officers and beneficial owners holding more than five percent of our common shares participated in the private placement:

| Director/Officer/                        
 Beneficial Owner                         |     | Total Purchase 
 Price          |           |     | Number of Common 
 Shares Purchased |           |
|:-----------------------------------------|:----|:---------------|----------:|:----|:-----------------|----------:|
| Richard Pilnik                           |     | $              |   150,000 |     |                  |    38,363 |
| Rick Pauls                               |     |                |    50,000 |     |                  |    12,787 |
| Michael Giuffre, M.D.                    |     |                |   254,150 |     |                  |    65,000 |
| Charles Semba, M.D.                      |     |                |    50,000 |     |                  |    12